Why now? Polls reveal that 74% of american citizens can't find the money for their medications, and Trump faces force to lower inflation and health care costs. The drug marketplace is characterized by counterproductive incentives, inefficiencies and anti-competitive tactics that obstruct healthy price competition.John Rother, AARP’s Policy and